My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 3 Dec 2009 | 7:25 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Pluristem Therapeutics, Inc.
Pluristem Therapeutics, Inc. (PSTI.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
PSTI
on other exchanges
As of 2 Dec 2009
1.07
USD
Price Change
+0.02
Percent Change
+1.90%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Shorrer, Doron
56
2006
Director
Meretzki, Hava
40
2005
Director
Ben-Yoram, Israel
48
2005
Director
Braun, Issac
56
2005
Director
Germain, Mark
59
2009
Director
Rosman, Nachum
63
2007
Director
Pines, Shai
55
2008
Director
Yanay, Yaky
38
2006
Chief Financial Officer, Secretary
Aberman, Zami
55
2006
Chairman of the Board, President, Chief Executive Officer
Find out more about PSTI.O
Insider Trading